FOLH1 and neoplasm: Our study was motivated in part by the observation that diverse therapies, including androgen deprivation, enzalutamide, and rapamycin, can increase the expression of PSMA protein expression, increase uptake of PSMA radioligands, and lead to improved anti-tumor responses in patients [25,26,27].